1 Study Coverage

• 1.1 Fostamatinib Product Introduction
• 1.2 Global Fostamatinib Outlook 2017 VS 2022 VS 2028
• 1.2.1 Global Fostamatinib Sales in US$ Million for the Year 2017-2028

1.2.2 Global Fostamatinib Sales in Volume for the Year 2017-2028

1.3 United States Fostamatinib Outlook 2017 VS 2022 VS 2028

1.3.1 United States Fostamatinib Sales in US$ Million for the Year 2017-2028

1.3.2 United States Fostamatinib Sales in Volume for the Year 2017-2028

1.4 Fostamatinib Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.4.1 The Market Share of United States Fostamatinib in Global, 2017 VS 2022 VS 2028

1.4.2 The Growth Rate of Fostamatinib Market Size, United States VS Global, 2017 VS 2022 VS 2028

1.5 Fostamatinib Market Dynamics

1.5.1 Fostamatinib Industry Trends

1.5.2 Fostamatinib Market Drivers

1.5.3 Fostamatinib Market Challenges

1.5.4 Fostamatinib Market Restraints

1.6 Study Objectives

1.7 Years Considered

2 Market by Brand

• 2.1 Fostamatinib Market Segment by Brand
• 2.1.1 Tavalisse

2.1.2 Tavlesse

2.2 Global Fostamatinib Market Size by Brand

2.2.1 Global Fostamatinib Sales in Value, by Brand (2017, 2022 & 2028)

2.2.2 Global Fostamatinib Sales in Volume, by Brand (2017, 2022 & 2028)

2.2.3 Global Fostamatinib Average Selling Price (ASP) by Brand (2017, 2022 & 2028)

2.3 United States Fostamatinib Market Size by Brand

2.3.1 United States Fostamatinib Sales in Value, by Brand (2017, 2022 & 2028)

2.3.2 United States Fostamatinib Sales in Volume, by Brand (2017, 2022 & 2028)

2.3.3 United States Fostamatinib Average Selling Price (ASP) by Brand (2017, 2022 & 2028)

3 Market by Application

• 3.1 Fostamatinib Market Segment by Application
• 3.1.1 Idiopathic (Immune) Thrombocytopenic Purpura

3.1.2 Waldenström's Macroglobulinemia

3.1.3 Autoimmune Haemolytic Anaemia

3.1.4 Other

3.2 Global Fostamatinib Market Size by Application

3.2.1 Global Fostamatinib Sales in Value, by Application (2017, 2022 & 2028)

3.2.2 Global Fostamatinib Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 Global Fostamatinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)

3.3 United States Fostamatinib Market Size by Application

3.3.1 United States Fostamatinib Sales in Value, by Application (2017, 2022 & 2028)

3.3.2 United States Fostamatinib Sales in Volume, by Application (2017, 2022 & 2028)

3.3.3 United States Fostamatinib Average Selling Price (ASP) by Application (2017, 2022 & 2028)

4 Global Fostamatinib Competitor Landscape by Company

• 4.1 Global Fostamatinib Market Size by Company
• 4.1.1 Top Global Fostamatinib Manufacturers Ranked by Revenue (2021)

4.1.2 Global Fostamatinib Revenue by Manufacturer (2017-2022)

4.1.3 Global Fostamatinib Sales by Manufacturer (2017-2022)

4.1.4 Global Fostamatinib Price by Manufacturer (2017-2022)

4.2 Global Fostamatinib Concentration Ratio (CR)

4.2.1 Fostamatinib Market Concentration Ratio (CR) (2017-2022)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Fostamatinib in 2021

4.2.3 Global Fostamatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Fostamatinib Manufacturing Base Distribution, Product Type

4.3.1 Global Fostamatinib Manufacturers, Headquarters and Distribution of Producing Region

4.3.2 Manufacturers Fostamatinib Product Type

4.3.3 Date of International Manufacturers Enter into Fostamatinib Market

4.4 Manufacturers Mergers & Acquisitions, Expansion Plans

4.5 United States Fostamatinib Market Size by Company

4.5.1 Top Fostamatinib Players in United States, Ranked by Revenue (2021)

4.5.2 United States Fostamatinib Revenue by Players (2020, 2021 & 2022)

4.5.3 United States Fostamatinib Sales by Players (2020, 2021 & 2022)

5 Global Fostamatinib Market Size by Region

• 5.1 Global Fostamatinib Market Size by Region: 2017 VS 2022 VS 2028
• 5.2 Global Fostamatinib Market Size in Volume by Region (2017-2028)
• 5.2.1 Global Fostamatinib Sales in Volume by Region: 2017-2022

5.2.2 Global Fostamatinib Sales in Volume Forecast by Region (2023-2028)

5.3 Global Fostamatinib Market Size in Value by Region (2017-2028)

5.3.1 Global Fostamatinib Sales in Value by Region: 2017-2022

5.3.2 Global Fostamatinib Sales in Value by Region: 2023-2028

6 Segment in Region Level & Country Level

• 6.1 North America
• 6.1.1 North America Fostamatinib Market Size YoY Growth 2017-2028

6.1.2 North America Fostamatinib Market Facts & Figures by Country (2017, 2022 & 2028)

6.1.3 United States

6.1.4 Canada

6.2 Asia-Pacific

6.2.1 Asia-Pacific Fostamatinib Market Size YoY Growth 2017-2028

6.2.2 Asia-Pacific Fostamatinib Market Facts & Figures by Region (2017, 2022 & 2028)

6.2.3 China

6.2.4 Japan

6.2.5 South Korea

6.2.6 India

6.2.7 Australia

6.2.8 China Taiwan

6.2.9 Indonesia

6.2.10 Thailand

6.2.11 Malaysia

6.3 Europe

6.3.1 Europe Fostamatinib Market Size YoY Growth 2017-2028

6.3.2 Europe Fostamatinib Market Facts & Figures by Country (2017, 2022 & 2028)

6.3.3 Germany

6.3.4 France

6.3.5 U.K.

6.3.6 Italy

6.3.7 Russia

6.4 Latin America

6.4.1 Latin America Fostamatinib Market Size YoY Growth 2017-2028

6.4.2 Latin America Fostamatinib Market Facts & Figures by Country (2017, 2022 & 2028)

6.4.3 Mexico

6.4.4 Brazil

6.4.5 Argentina

6.5 Middle East and Africa

6.5.1 Middle East and Africa Fostamatinib Market Size YoY Growth 2017-2028

6.5.2 Middle East and Africa Fostamatinib Market Facts & Figures by Country (2017, 2022 & 2028)

6.5.3 Turkey

6.5.4 Saudi Arabia

6.5.5 UAE

7 Company Profiles

• 7.1 Rigel Pharmaceuticals, Inc
• 7.1.1 Rigel Pharmaceuticals, Inc Corporation Information

7.1.2 Rigel Pharmaceuticals, Inc Description and Business Overview

7.1.3 Rigel Pharmaceuticals, Inc Fostamatinib Sales, Revenue and Gross Margin (2017-2022)

7.1.4 Rigel Pharmaceuticals, Inc Fostamatinib Products Offered

7.1.5 Rigel Pharmaceuticals, Inc Recent Development

7.2 Kissei Pharmaceutical Co., Ltd

7.2.1 Kissei Pharmaceutical Co., Ltd Corporation Information

7.2.2 Kissei Pharmaceutical Co., Ltd Description and Business Overview

7.2.3 Kissei Pharmaceutical Co., Ltd Fostamatinib Sales, Revenue and Gross Margin (2017-2022)

7.2.4 Kissei Pharmaceutical Co., Ltd Fostamatinib Products Offered

7.2.5 Kissei Pharmaceutical Co., Ltd Recent Development

7.3 Grifols

7.3.1 Grifols Corporation Information

7.3.2 Grifols Description and Business Overview

7.3.3 Grifols Fostamatinib Sales, Revenue and Gross Margin (2017-2022)

7.3.4 Grifols Fostamatinib Products Offered

7.3.5 Grifols Recent Development

7.4 JW Pharmaceutical Corporation

7.4.1 JW Pharmaceutical Corporation Corporation Information

7.4.2 JW Pharmaceutical Corporation Description and Business Overview

7.4.3 JW Pharmaceutical Corporation Fostamatinib Sales, Revenue and Gross Margin (2017-2022)

7.4.4 JW Pharmaceutical Corporation Fostamatinib Products Offered

7.4.5 JW Pharmaceutical Corporation Recent Development

7.5 Medison Pharma Canada

7.5.1 Medison Pharma Canada Corporation Information

7.5.2 Medison Pharma Canada Description and Business Overview

7.5.3 Medison Pharma Canada Fostamatinib Sales, Revenue and Gross Margin (2017-2022)

7.5.4 Medison Pharma Canada Fostamatinib Products Offered

7.5.5 Medison Pharma Canada Recent Development

7.6 AstraZeneca

7.6.1 AstraZeneca Corporation Information

7.6.2 AstraZeneca Description and Business Overview

7.6.3 AstraZeneca Fostamatinib Sales, Revenue and Gross Margin (2017-2022)

7.6.4 AstraZeneca Fostamatinib Products Offered

7.6.5 AstraZeneca Recent Development

8 Industry Chain and Sales Channels Analysis

• 8.1 Fostamatinib Industry Chain Analysis
• 8.2 Fostamatinib Key Raw Materials
• 8.2.1 Key Raw Materials

8.2.2 Fostamatinib Distributors

8.3 Fostamatinib Production Mode & Process

8.4 Fostamatinib Sales and Marketing

8.4.1 Fostamatinib Sales Channels

8.4.2 Fostamatinib Distributors

8.5 Fostamatinib Customers

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
• 10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

Market Analysis and Insights: Global and United States Fostamatinib Market
This report focuses on global and United States Fostamatinib market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Fostamatinib market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Brand, Tavalisse accounting for % of the Fostamatinib global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Idiopathic (Immune) Thrombocytopenic Purpura was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Fostamatinib market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

Global Fostamatinib Scope and Market Size

Fostamatinib market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Fostamatinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Fostamatinib market size by players, by Brand and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Brand, the Fostamatinib market is segmented into

Tavalisse

Tavlesse

Segment by Application, the Fostamatinib market is segmented into

Idiopathic (Immune) Thrombocytopenic Purpura

Waldenström's Macroglobulinemia

Autoimmune Haemolytic Anaemia

Other

Regional and Country-level Analysis

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Landscape and Fostamatinib Market Share Analysis

Fostamatinib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Fostamatinib business, the date to enter into the Fostamatinib market, Fostamatinib product introduction, recent developments, etc.

The major vendors covered:

Rigel Pharmaceuticals, Inc

Kissei Pharmaceutical Co., Ltd

Grifols

JW Pharmaceutical Corporation

Medison Pharma Canada

AstraZeneca